Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part B.
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects; D001146:Arrhythmia, Sinus / Q000188:drug therapy / Q000209:etiology; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D001283:Atrioventricular Node / Q000187:drug effects; D003327:Coronary Disease / Q000150:complications; D004074:Digitoxin / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D007275:Injections, Intravenous; D009203:Myocardial Infarction / Q000150:complications; D011217:Practolol / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D011433:Propranolol / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use; D011802:Quinidine / Q000008:administration & dosage
D000319:Adrenergic beta-Antagonists; D000929:Antidepressive Agents, Tricyclic; D011433:Propranolol; D004074:Digitoxin; D011802:Quinidine; D011217:Practolol